$270 Million is the total value of HARBOURVEST PARTNERS LLC's 36 reported holdings in Q3 2020. The portfolio turnover from Q2 2020 to Q3 2020 was 60.7% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SWI | Solarwinds Corp. | $160,133,000 | +15.1% | 7,872,801 | 0.0% | 59.26% | -1.2% | |
| KLDO | Buy | Kaleido BioSciences, Inc. | $23,435,000 | +72.0% | 1,920,027 | +4.7% | 8.67% | +47.7% |
| EVLO | Evelo Biosciences, Inc. | $16,145,000 | +7.6% | 3,063,505 | 0.0% | 5.97% | -7.7% | |
| AXLA | Axcella Health, Inc. | $12,973,000 | -16.5% | 2,807,981 | 0.0% | 4.80% | -28.3% | |
| TDOC | New | TelaDoc Health, Inc. | $11,169,000 | – | 50,943 | +100.0% | 4.13% | – |
| ONEM | New | 1Life Healthcare, Inc. | $9,968,000 | – | 351,480 | +100.0% | 3.69% | – |
| RUBY | Rubius Therapeutics, Inc. | $4,944,000 | -16.2% | 986,878 | 0.0% | 1.83% | -28.1% | |
| PS | Buy | PluralSight, Inc. | $3,029,000 | +216.2% | 176,807 | +233.2% | 1.12% | +171.4% |
| PGNY | New | Progyny, Inc. | $2,577,000 | – | 87,574 | +100.0% | 0.95% | – |
| ISEE | Buy | IVERIC Bio, Inc. | $2,497,000 | +58.6% | 442,810 | +43.5% | 0.92% | +36.3% |
| LOV | Spark Networks SEsponsored adr | $2,458,000 | +48.2% | 502,576 | 0.0% | 0.91% | +27.3% | |
| LC | LendingClub Corp. | $2,418,000 | +3.5% | 513,440 | 0.0% | 0.90% | -11.1% | |
| NTNX | New | Nutanix, Inc. | $2,352,000 | – | 106,049 | +100.0% | 0.87% | – |
| PD | New | PagerDuty, Inc. | $1,841,000 | – | 67,891 | +100.0% | 0.68% | – |
| SFIX | Stitchfix, Inc. | $1,806,000 | +8.8% | 66,571 | 0.0% | 0.67% | -6.7% | |
| New | Crispr Therapeutics AGnamen akt | $1,793,000 | – | 21,439 | +100.0% | 0.66% | – | |
| YEXT | Yext, Inc. | $1,748,000 | -8.6% | 115,147 | 0.0% | 0.65% | -21.6% | |
| ZUO | Sell | Zuora, Inc. | $1,695,000 | -29.0% | 163,894 | -12.5% | 0.63% | -39.1% |
| CNST | New | Constellation Pharmaceuticals, Inc. | $1,005,000 | – | 49,614 | +100.0% | 0.37% | – |
| PHR | New | Phreesia, Inc. | $789,000 | – | 24,562 | +100.0% | 0.29% | – |
| VCYT | New | Veracyte, Inc. | $766,000 | – | 23,591 | +100.0% | 0.28% | – |
| LYFT | Lyft, Inc. | $710,000 | -16.6% | 25,785 | 0.0% | 0.26% | -28.3% | |
| TRVN | Trevena, Inc. | $699,000 | +99.1% | 233,850 | 0.0% | 0.26% | +71.5% | |
| CTMX | Cytomx Therapeutics, Inc. | $527,000 | -20.2% | 79,193 | 0.0% | 0.20% | -31.3% | |
| PTI | Proteostasis Therapeutics, Inc. | $485,000 | -19.7% | 440,627 | 0.0% | 0.18% | -31.2% | |
| CSLT | Castlight Health, Inc. | $394,000 | +35.9% | 349,070 | 0.0% | 0.15% | +16.8% | |
| ARVN | New | Arvinas, Inc. | $393,000 | – | 16,666 | +100.0% | 0.14% | – |
| AR | Antero Resources LLC | $363,000 | +8.4% | 131,895 | 0.0% | 0.13% | -6.9% | |
| EPZM | Epizyme, Inc. | $295,000 | -25.5% | 24,686 | 0.0% | 0.11% | -36.3% | |
| BDTX | New | Black Diamond Therapeutics, Inc. | $290,000 | – | 9,581 | +100.0% | 0.11% | – |
| XGN | Exagen, Inc. | $282,000 | -12.4% | 25,982 | 0.0% | 0.10% | -25.2% | |
| REAL | New | The RealReal, Inc. | $106,000 | – | 7,300 | +100.0% | 0.04% | – |
| NXTC | NextCure, Inc. | $88,000 | -59.1% | 10,044 | 0.0% | 0.03% | -64.5% | |
| METC | Ramaco Resources, Inc. | $52,000 | +62.5% | 14,951 | 0.0% | 0.02% | +35.7% | |
| HNRG | Hallador Energy Resources, Inc. | $9,000 | 0.0% | 14,270 | 0.0% | 0.00% | -25.0% | |
| TENB | Exit | Tenable Holdings, Inc. | $0 | – | -55,444 | -100.0% | -0.71% | – |
| SONO | Exit | Sonos, Inc. | $0 | – | -303,253 | -100.0% | -1.91% | – |
| PINS | Exit | Pinterest, Inc. | $0 | – | -211,336 | -100.0% | -2.02% | – |
| FNJN | Exit | Finjan Holdings, Inc. | $0 | – | -4,303,435 | -100.0% | -2.86% | – |
| WORK | Exit | Slack Technologies, Inc. | $0 | – | -285,325 | -100.0% | -3.82% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-11-12
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
| 13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.